VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 333 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2016. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $385,000 | -69.2% | 15,700 | +27.6% | 0.03% | -69.8% |
| Q4 2015 | $1,250,000 | -43.0% | 12,300 | 0.0% | 0.09% | -43.0% |
| Q3 2015 | $2,194,000 | -19.7% | 12,300 | 0.0% | 0.15% | -11.7% |
| Q2 2015 | $2,732,000 | +11.8% | 12,300 | 0.0% | 0.17% | +19.6% |
| Q1 2015 | $2,443,000 | +38.8% | 12,300 | 0.0% | 0.14% | +36.2% |
| Q4 2014 | $1,760,000 | +9.0% | 12,300 | 0.0% | 0.10% | +11.7% |
| Q3 2014 | $1,614,000 | +4.1% | 12,300 | 0.0% | 0.09% | -3.1% |
| Q2 2014 | $1,551,000 | -36.5% | 12,300 | -40.9% | 0.10% | -45.2% |
| Q4 2013 | $2,442,000 | – | 20,800 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,373,210 | $47,796,000 | 39.06% |
| Claren Road Asset Management, LLC | 77,527 | $1,561,000 | 18.46% |
| Okumus Fund Management Ltd. | 4,242,012 | $85,434,000 | 14.79% |
| Chou Associates Management | 1,446,843 | $29,139,000 | 11.12% |
| FARLEY CAPITAL L.P. | 307,458 | $6,192,000 | 9.65% |
| HAP Trading, LLC | 3,129,700 | $112,397,000 | 6.58% |
| Pershing Square Capital Management | 21,591,122 | $434,845,000 | 5.79% |
| NORTH TIDE CAPITAL, LLC | 2,500,000 | $50,350,000 | 5.61% |
| Convector Capital Management, LP | 192,000 | $3,867,000 | 5.34% |
| Nebula Capital Management, LP | 31,770 | $640,000 | 5.07% |